1. Gupta N, Limbago BM, Patel JB, Kallen AJ. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis. 2011; 53:60–67. PMID:
21653305.
2. Nordmann P, Naas T, Poirel L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2011; 17:1791–1798. PMID:
22000347.
3. Yano H, Ogawa M, Endo S, Kakuta R, Kanamori H, Inomata S, et al. High frequency of IMP-6 among clinical isolates of metallo-β-lactamase-producing
Escherichia coli in Japan. Antimicrob Agents Chemother. 2012; 56:4554–4555. PMID:
22664972.
4. Saito K, Nakano R, Suzuki Y, Nakano A, Ogawa Y, Yonekawa S, et al. Suitability of carbapenem inactivation method (CIM) for detection of IMP metallo-β-lactamase-producing Enterobacteriaceae. J Clin Microbiol. 2017; 55:1220–1222. PMID:
28100600.
5. Yano H, Kuga A, Okamoto R, Kitasato H, Kobayashi T, Inoue M. Plasmid-encoded metallo-β-lactamase (IMP-6) conferring resistance to carbapenems, especially meropenem. Antimicrob Agents Chemother. 2001; 45:1343–1348. PMID:
11302793.
6. Kayama S, Shigemoto N, Kuwahara R, Onodera M, Yokozaki M, Ohge H, et al. Rapid detection of
blaIMP-6 by amplification refractory mutation system. J Microbiol Methods. 2012; 88:182–184. PMID:
22108497.
7. Newton CR, Graham A, Heptinstall LE, Powell SJ, Summers C, Kalsheker N, et al. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res. 1989; 17:2503–2516. PMID:
2785681.
8. Nakano R, Nakano A, Hikosaka K, Kawakami S, Matsunaga N, Asahara M, et al. First report of metallo-β-lactamase NDM-5-producing
Escherichia coli in Japan. Antimicrob Agents Chemother. 2014; 58:7611–7612. PMID:
25246390.
9. CLSI. Performance standards for antimicrobial susceptibility testing. 22nd ed. Wayne, PA: Clinical and Laboratory Standards Institute;2012. CLSI supplement M100-S22.